Hi-Tech Pharmacal (HITK) reported first quarter EPS of $0.67 Wednesday morning, down from $0.73 in the prior year period. The consensus estimate was for EPS of $0.51.
Hi-Tech Pharmacal gapped up Wednesday and is now trading higher by 1.31 at $19.67. The stock has broken out to a month and a half high and has also re-crossed its 50-day moving average.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.